Qualigen Therapeutics's total assets for Q2 2025 were $3.96M, an increase of 39.16% from the previous quarter. QLGN total liabilities were $5.61M for the fiscal quarter, a 99.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.